Enhabit EVP Jolley granted 12,050 shares

Jolley Julie Diane reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Jolley Julie Diane reported acquisition or exercise transactions in this Form 4 filing.

Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported an amended insider filing reflecting a grant of common stock. She received 12,050 shares of Enhabit common stock on March 6, 2026 at a stated value of $13.61 per share as a stock award, increasing her direct holdings to 142,716 shares after the transaction. The amendment notes this award was originally omitted due to a clerical error, so the filing updates previously reported ownership rather than recording an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 12,050 shares

Grant/Award 1 txn

Insider Jolley Julie Diane

Role EVP of Home Health Operations

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,050	$13.61	$164K

Holdings After Transaction: Common Stock — 142,716 shares (Direct)

Footnotes (1)

1. F1. Due to a clerical error, this award was omitted from the original filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Enhabit (EHAB) executive Julie Diane Jolley report in this Form 4/A?

Julie Diane Jolley reported an amended Form 4/A showing a grant of 12,050 Enhabit common shares on March 6, 2026. The filing corrects an earlier report that had omitted this stock award due to a clerical error.

Was the Enhabit (EHAB) Form 4/A transaction a market purchase or sale?

The Form 4/A shows a stock award, not a market trade. Jolley acquired 12,050 Enhabit common shares as a grant at a stated value of $13.61 per share, classified as a compensation-related acquisition.

How many Enhabit (EHAB) shares does Julie Diane Jolley hold after this award?

After the reported stock award, Julie Diane Jolley directly holds 142,716 shares of Enhabit common stock. This total reflects the inclusion of the 12,050-share grant that had been omitted from the original Form 4 filing.

Why was an amended Form 4/A filed for Enhabit (EHAB)?

An amended Form 4/A was filed because a prior insider report missed a stock award. A footnote explains that, due to a clerical error, the 12,050-share grant to Julie Diane Jolley had been omitted and is now properly disclosed.

What role does Julie Diane Jolley hold at Enhabit (EHAB)?

Julie Diane Jolley serves as Enhabit’s Executive Vice President of Home Health Operations. The Form 4/A details a stock grant to her in this capacity, documenting compensation-related equity rather than a discretionary market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 09:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jolley Julie Diane

(Last) (First) (Middle)

6688 N. CENTRAL EXPRESSWAY

SUITE 1300

(Street)

DALLAS TX 75206

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP of Home Health Operations

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		A		12,050(1)	A	$13.61	142,716	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Due to a clerical error, this award was omitted from the original filing.

Remarks:

	/s/ Sarah W. Braley, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.